Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 2
1 February 2005
Molecular Cancer Therapeutics Cover Image for Volume 4, Issue 2
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model
Kazuki Yamanaka; Martin E. Gleave; Isao Hara; Mototsugu Muramaki; Hideaki Miyake
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
(−)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer
Liang Xu; Dajun Yang; Shaomeng Wang; Wenhua Tang; Meilan Liu; Mary Davis; Jianyong Chen; James M. Rae; Theodore Lawrence; Marc E. Lippman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation
Santosh K. Katiyar; Anshu M. Roy; Manjeshwar S. Baliga
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3
Ting Chen; Yolande Pengetnze; Christopher C. Taylor
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Gonadotropin-releasing hormone receptor–targeted gene therapy of gynecologic cancers
Carsten Gründker; Abdohamid Huschmand Nia; Günter Emons
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin
Chunhong Yan; Md. S. Jamaluddin; Bharat Aggarwal; Jeffrey Myers; Douglas D. Boyd
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
H-RAS V12–induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent
Rubén W. Carón; Adly Yacoub; Xiaoyu Zhu; Clint Mitchell; Song Iy Han; Takehiko Sasazuki; Senji Shirasawa; Michael P. Hagan; Steven Grant; Paul Dent
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival
Rubén W. Carón; Adly Yacoub; Min Li; Xiaoyu Zhu; Clint Mitchell; Young Hong; William Hawkins; Takehiko Sasazuki; Senji Shirasawa; Alan P. Kozikowski; Philip A. Dennis; Michael P. Hagan; Steven Grant; Paul Dent
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members
Deborah DeFeo-Jones; Stanley F. Barnett; Sheng Fu; Paula J. Hancock; Kathleen M. Haskell; Karen R. Leander; Elizabeth McAvoy; Ronald G. Robinson; Mark E. Duggan; Craig W. Lindsley; Zhijian Zhao; Hans E. Huber; Raymond E. Jones
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells
Ching-Huai Ko; Shing-Chuan Shen; Tony J.F. Lee; Yen-Chou Chen
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Sulindac enhances adenoviral vector expressing mda-7/IL-24–mediated apoptosis in human lung cancer
Yasuhisa Oida; Began Gopalan; Ryo Miyahara; Satoshi Inoue; Cynthia D. Branch; Abner M. Mhashilkar; E. Lin; B. Nebiyou Bekele; Jack A. Roth; Sunil Chada; Rajagopal Ramesh
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells
Johnathan C. Lai; Luba Benimetskaya; Anastasia Khvorova; Sijian Wu; Emily Hua; Paul Miller; C.A. Stein
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer
Allan Y. Chen; Shyh-Jen Shih; Liza N. Garriques; Mace L. Rothenberg; Michael Hsiao; Dennis P. Curran
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate
Fabian D. Arditti; Aharon Rabinkov; Talia Miron; Yair Reisner; Alain Berrebi; Meir Wilchek; David Mirelman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Minireview

Marine natural products as anticancer drugs
T. Luke Simmons; Eric Andrianasolo; Kerry McPhail; Patricia Flatt; William H. Gerwick
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
Expanding the Targeted Protein Degradation Arsenal
AI Model Could Make Cachexia Detection Easier
Drugging WRN: Clinical Proof-of-Concept Established
View more recent articles
Breaking
ADC for Lung Cancer Approved
FDA Announces Cancer Outreach Initiative
First Oral Treatment for Adrenal Tumors OK’d
View more recent articles
Research Watch
BRCA2 Mitigates PARP1 Retention at DNA Repair Sites to Stabilize RAD51
ROS Sensing Regulates Mitochondrial Translation and Chemotherapy Response
Dietary Fat Promotes Triple-Negative Breast Cancer through FABP5–mTOR
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept